Evidence map›Paper›PMID 36425643›Full record

ArticleBiomedical optics express2022

Development of a multimodal mobile colposcope for real-time cervical cancer detection.

Jackson B Coole, David Brenes, Júlio César Possati-Resende, Márcio Antoniazzi, Bruno de Oliveira Fonseca, Yajur Maker, Alex Kortum, Imran S Vohra, Richard A Schwarz, Jennifer Carns and 7 more

Open access · goldAbstract read
In one paragraph

Article in Biomedical optics express, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Optical imaging technologies forCurrent opinion in biomedical engineering · 2023
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 4 countries.

Jackson B CooleRice University, Department of Bioengineering, Houston, TX 77005, USA.ORCID https://orcid.org/0000-0002-8821-4139
David BrenesRice University, Department of Bioengineering, Houston, TX 77005, USA.
Júlio César Possati-ResendeBarretos Cancer Hospital, Department of Prevention, Barretos, Brazil.
Márcio AntoniazziBarretos Cancer Hospital, Department of Prevention, Barretos, Brazil.
Bruno de Oliveira FonsecaBarretos Cancer Hospital, Department of Prevention, Barretos, Brazil.
Yajur MakerRice University, Department of Bioengineering, Houston, TX 77005, USA.
Alex KortumRice University, Department of Bioengineering, Houston, TX 77005, USA.
Imran S VohraRice University, Department of Bioengineering, Houston, TX 77005, USA.
Richard A SchwarzRice University, Department of Bioengineering, Houston, TX 77005, USA.
Jennifer CarnsRice University, Department of Bioengineering, Houston, TX 77005, USA.
Karen Cristina Borba SouzaBarretos Cancer Hospital, Teaching and Research Institute, Barretos, Brazil.
Iara Viana Vidigal SantanaBarretos Cancer Hospital, Department of Pathology, Barretos, Brazil.
Regis KreitchmannFederal University of Health Sciences of Porto Alegre (UFCSPA)/Santa Casa Hospital of Porto Alegre, Department of Obstetrics and Gynecology, Porto Alegre, Brazil.
Mila P SalcedoFederal University of Health Sciences of Porto Alegre (UFCSPA)/Santa Casa Hospital of Porto Alegre, Department of Obstetrics and Gynecology, Porto Alegre, Brazil.
Nirmala RamanujamDuke University, Department of Biomedical Engineering, Durham, NC 27708, USA.
Kathleen M SchmelerThe University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston, TX 77005, USA.
Rebecca Richards-KortumRice University, Department of Bioengineering, Houston, TX 77005, USA.
Rice University · USHospital de Câncer de Barretos · BRThe University of Texas MD Anderson Cancer Center · USDuke University · USUniversidade Federal de Ciências da Saúde de Porto Alegre · BR

Funding

Low-cost mobile colposcopy and confocal imaging for global prevention of cervical cancerR01CA251911 · NCI · RICE UNIVERSITY · PI RICHARDS-KORTUM, REBECCA R., SCHMELER, KATHLEEN · 2020 to 2024
$2.8M
NCI NIH HHS R01 CA251911
6 · The paper itself

Abstract

Cervical cancer remains a leading cause of cancer death among women in low-and middle-income countries. Globally, cervical cancer prevention programs are hampered by a lack of resources, infrastructure, and personnel. We describe a multimodal mobile colposcope (MMC) designed to diagnose precancerous cervical lesions at the point-of-care without the need for biopsy. The MMC integrates two complementary imaging systems: 1) a commercially available colposcope and 2) a high speed, high-resolution, fiber-optic microendoscope (HRME). Combining these two image modalities allows, for the first time, the ability to locate suspicious cervical lesions using widefield imaging and then to obtain co-registered high-resolution images across an entire lesion. The MMC overcomes limitations of high-resolution imaging alone; widefield imaging can be used to guide the placement of the high-resolution imaging probe at clinically suspicious regions and co-registered, mosaicked high-resolution images effectively increase the field of view of high-resolution imaging. Representative data collected from patients referred for colposcopy at Barretos Cancer Hospital in Brazil, including 22,800 high resolution images and 9,900 colposcope images, illustrate the ability of the MMC to identify abnormal cervical regions, image suspicious areas with subcellular resolution, and distinguish between high-grade and low-grade dysplasia.

Identifiers

PMID36425643
PMCPMC9664871
OpenAlexW4293206796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.